ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 100 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.65 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $285,000 | +32.6% | 15,834 | +85.5% | 0.00% | 0.0% |
| Q1 2021 | $215,000 | +35.2% | 8,537 | -89.8% | 0.00% | 0.0% |
| Q4 2019 | $159,000 | +23.3% | 83,924 | +42.5% | 0.00% | 0.0% |
| Q2 2019 | $129,000 | -53.1% | 58,902 | +28.3% | 0.00% | -66.7% |
| Q1 2019 | $275,000 | -66.9% | 45,906 | -59.2% | 0.00% | -70.0% |
| Q4 2018 | $832,000 | +82.9% | 112,590 | +258.9% | 0.01% | +100.0% |
| Q3 2018 | $455,000 | +58.5% | 31,370 | +118.2% | 0.01% | +25.0% |
| Q2 2018 | $287,000 | -58.0% | 14,375 | -63.2% | 0.00% | -63.6% |
| Q1 2018 | $684,000 | +41.3% | 39,058 | +99.1% | 0.01% | +37.5% |
| Q4 2017 | $484,000 | +66.3% | 19,616 | +82.7% | 0.01% | -33.3% |
| Q4 2016 | $291,000 | – | 10,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |